Kirsten Gruis, M.D., M.S. joined Edgewise Therapeutics March 2020 as our Chief Medical Officer. Dr. Gruis is a board-certified Neuromuscular neurologist with recent experience as the Global head of the Neuromuscular franchise leading the development of SMA (spinal muscular atrophy) and DMD (Duchenne muscular dystrophy) therapeutics at Roche. Pri...
Roles at Edgewise Therapeutics